Conference Agenda

Emerging healthcare needs, including global healthcare, personalized medicine, and point-of-care applications are demanding breakthrough advancements in diagnostic and bioanalytical tools. Towards this goal, our lab is developing next-generation nanophotonic lab-on-a-chip systems offering high performance in accuracy, response time, integration, throughput, and affordability while reducing complexity, cost and device footprint. We build optical biosensors, spectroscopy, bioimaging and microarray technologies to sensitively detect and analyze biological samples, including disease biomarkers, misfolded protein aggregates, nucleic acids, drugs, and living cells. To achieve our objectives we uniquely combine nanophotonics with advanced nanofabrication, microfluidics, surface chemistry, and data science techniques. In particular, we engineer optical metasurfaces exploiting plasmonics and dielectric resonators to fundamentally increase interaction of light with nanometric sized biomolecules. In this talk, I will present some of our recent works on surface enhanced mid-infrared spectroscopy such as an AI-aided optofluidic biosensor capable of differentiating misfolded disease proteins and high-Q gradient metasurfaces for ultra-broadband operation as well as describe nanophotonic single-cell and organoid microarrays that can enable high-throughput monitoring of extracellular secretion for screening applications.